Cargando…
FAM193A is a positive regulator of p53 activity
Inactivation of the p53 tumor suppressor, either by mutations or through hyperactivation of repressors such as MDM2 and MDM4, is a hallmark of cancer. Although many inhibitors of the p53-MDM2/4 interaction have been developed, such as Nutlin, their therapeutic value is limited by highly heterogeneou...
Autores principales: | Szwarc, Maria M., Guarnieri, Anna L., Joshi, Molishree, Duc, Huy N., Laird, Madison C., Pandey, Ahwan, Khanal, Santosh, Dohm, Emily, Bui, Aimee K., Sullivan, Kelly D., Galbraith, Matthew D., Andrysik, Zdenek, Espinosa, Joaquin M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10164416/ https://www.ncbi.nlm.nih.gov/pubmed/36897777 http://dx.doi.org/10.1016/j.celrep.2023.112230 |
Ejemplares similares
-
Identification of a core TP53 transcriptional program with highly distributed tumor suppressive activity
por: Andrysik, Zdenek, et al.
Publicado: (2017) -
Cell differentiation modifies the p53 transcriptional program through a combination of gene silencing and constitutive transactivation
por: Tatavosian, Roubina, et al.
Publicado: (2023) -
Mechanisms of transcriptional regulation by p53
por: Sullivan, Kelly D, et al.
Publicado: (2018) -
Multi-omics analysis reveals contextual tumor suppressive and oncogenic gene modules within the acute hypoxic response
por: Andrysik, Zdenek, et al.
Publicado: (2021) -
A DR4:tBID axis drives the p53 apoptotic response by promoting oligomerization of poised BAX
por: Henry, Ryan E, et al.
Publicado: (2012)